Aytu BioPharma, Inc.

NASDAQ:AYTU

1.94 (USD) • At close November 1, 2024
Bedrijfsnaam Aytu BioPharma, Inc.
Symbool AYTU
Munteenheid USD
Prijs 1.938
Beurswaarde 11,913,668
Dividendpercentage 0%
52-weken bereik 1.9 - 3.45
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Joshua R. Disbrow
Website https://aytubio.com

An error occurred while fetching data.

Over Aytu BioPharma, Inc.

Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of

Vergelijkbare Aandelen

Cellectar Biosciences, Inc. logo

Cellectar Biosciences, Inc.

CLRB

2.03 USD

Sio Gene Therapies Inc. logo

Sio Gene Therapies Inc.

SIOX

0.415 USD

Landos Biopharma, Inc. logo

Landos Biopharma, Inc.

LABP

22.93 USD

Onconova Therapeutics, Inc. logo

Onconova Therapeutics, Inc.

ONTX

0.995 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)